Acasti Pharma (ACST) EBITDA (2013 - 2025)
Acasti Pharma (ACST) EBITDA from Feb 28, 2013 to Dec 31, 2025. The TTM Acasti Pharma (ACST) EBITDA is -$11M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Acasti Pharma (ACST) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -33.08% |
| 3 Years TTM | -15.08% |
| 5 Years TTM | -0.14% |
| 10 Years TTM | +4.67% |
| All Time TTM | +2.44% |
Annual EBITDA change of Acasti Pharma (ACST)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$17M | +46.10% |
| 2024 | -$11M | -37.03% |
| 2023 | -$18M | +18.12% |
| 2022 | -$15M | +56.69% |
| 2021 | -$9.79M | -55.74% |
| 2020 | -$22M | -31.03% |
| 2019 | -$32M | +435.39% |
| 2017 | -$5.99M | +7.93% |
| 2016 | -$5.55M | -35.16% |
| 2015 | -$8.56M | +1.18% |
| 2014 | -$8.46M | +34.71% |
| 2013 | -$6.28M | N/A |